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Purpose: To report the role of Healon5TM injection combined with medications in patient with 
malignant glaucoma after trabeculectomy with unplanned zonulectomy.
Methods: Two days after trabeculectomy with unplanned zonulectomy for neovascular glau-
coma in an eye with diabetic retinopathy, a patient developed malignant glaucoma due to the 
ciliovitreal block caused by the vitreous herniation through the peripheral iridectomy to the 
limbal incision with flat bleb and anterior chamber, and the intraocular pressure was elevated 
to 33 mmHg. The medications for the management of malignant glaucoma failed to relieve the 
malignant mechanism, and Healon5TM, a viscoadaptive, viscoelastic, and ophthalmic viscosurgi-
cal device, was injected through a paracentesis until the anterior chamber became deep enough 
to block the vitreous herniation to the limbal incision.
Results: After Healon5TM injection, the intraocular pressure was reduced enough that the bleb 
was re-formed, and the anterior chamber remained deep, even without medication.
Conclusions: In patients presenting with malignant glaucoma after trabeculectomy with 
unplanned zonulectomy, Healon5TM injection, combined with medications, may be a safe and 
effective approach before performing vitrectomy.
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Case report
A 55-year-old Japanese man was referred to the Keio University Hospital with pain 
in the right eye. He had been diagnosed with diabetes mellitus eight years earlier. His 
best-corrected visual acuity (BCVA) was 4/200 in the right eye and 4/4 in the left eye. 
The intraocular pressures (IOPs) were 51 mmHg in the right eye and 18 mmHg in the 
left eye. Ophthalmological examination showed iris rubeosis and proliferative diabetic 
retinopathy without vitreous hemorrhage in his right eye. The angle of the right eye 
was difficult to examine because of a shagreen patch on the cornea. The angle of the 
left anterior chamber was open (Shaffer 4) but profuse neovascularization was found 
in the entire angle. Panretinal photocoagulation was performed on both eyes, and the 
right eye was medically treated with topical 0.5% timolol maleate, 1% brinzolamide, 
0.005% latanoprost, oral acetazolamide, and intravenous mannitol. However, this 
regimen failed to control the IOP adequately, and trabeculectomy with mitomycin C 
was performed.
At the end of the operation, a bleb did not form when balanced salt solution was 
injected into the anterior chamber, and the digitally-measured IOP appeared to be 
high. The conjunctiva and scleral flap were opened again, and herniated vitreous was 
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found in the bleb. An unplanned zonulectomy appeared to 
have been performed during the peripheral iridectomy. After 
removal of as much vitreous as possible by forceps, the bleb 
was reconstructed and the IOP felt normal when determined 
digitally.
Two days after the operation, the bleb and anterior cham-
ber were flat, and the IOP was 33 mmHg (Figure 1). Because 
a ciliovitreal block, caused by a recurrence of the vitreous 
herniation through the peripheral iridectomy to the limbal inci-
sion, was suspected, and no signs of choroidal effusion were 
detected, a diagnosis of malignant glaucoma was made.
Topical atropine, beta-blocker, oral acetazolamide, and 
intravenous mannitol did not relieve the malignant glaucoma, 
and the IOP remained over 20 mmHg for 3 days. On the 5th 
postoperative day, Healon5TM (Abbott Medical Optics, Santa 
Ana, CA), a viscoadaptive, viscoelastic, and an ophthalmic 
viscosurgical device, was injected through a paracentesis into 
the anterior chamber. However, the Healon5TM did not block 
the aqueous humor route to the area of the trabeculectomy. 
The same medications were continued.
On the next day, the IOP was reduced to 14 mmHg, the 
bleb was reconstructed, and the anterior chamber remained 
deep (Figure 2). All the antiglaucoma medications were 
discontinued at this time. On the 18th postoperative day, 
phacoemulsification and intraocular lens implantation 
was performed on the right eye, because the cataract had 
  progressed, due to a lens touch with the iridocornea during 
the malignant glaucoma attack. The BCVA improved to 
4/10 in the right eye after the cataract surgery. The patient’s 
last visit was 4 months after the Healon5TM injection. The 
anterior chamber remained deep and the bleb continued to 
function. The IOP was well controlled at 8 to 14 mmHg 
without antiglaucoma medications.
Discussion
In our case, because a herniation of vitreous into the filtration 
area was suspected as the cause of the malignant glaucoma, 
we injected Healon5TM into the anterior chamber, in order 
to create a deep anterior chamber, and to block the vitreous 
herniation. This approach was successful, and the malignant 
mechanism did not recur in the period of almost two weeks, 
until a more rigid and deep anterior chamber was constructed 
by cataract surgery.
Brown et al reported Nd YAG hyaloidotomy through the 
surgical iridotomy site in phakic malignant glaucoma,1 but 
this method is thought to have its limitations.
Our approach is simple and safe; it may be effective for 
patients with findings similar to our case, and would be an 
option to consider before performing vitrectomy. Hoffman 
et al reported a case of flat anterior chamber due to over-
filtration and hypotony after trabeculectomy, in which the 
injection of Healon5TM deepened the anterior chamber.2 We 
suggest that Healon5TM injection combined with antiglau-
coma medications may be effective even in treating malignant 
glaucoma similar to our case, for a flat anterior chamber.
In watertight surgery such as cataract surgery, sodium 
hyaluronate interferes with the aqueous outflow, and the IOP 
rises.3,4 However, there is still filtering after trabeculectomy, 
and low viscosity sodium hyaluronate, such as Healon5TM, 
flows out through the filtration area and does not maintain 
the depth of the anterior chamber. Dick et al reported that the 
mean viscosity at zero shear rate was 243 Pas for Healon5TM, 
and 5525 Pas for Healon5TM.5 The superviscous properties of 
Healon5TM under low turbulence conditions may be helpful in 
maintaining the anterior chamber depth, to preserve aqueous 
outflow through the filtration area.
The loss of corneal endothelial cell after trabeculectomy 
is caused by a flat and shallow anterior chamber in most 
Figure  1  Flat  anterior  chamber  two  days  after  trabeculectomy.  The  bleb  and 
anterior chamber are flat and the intraocular pressure was elevated to 33 mmHg.
Figure 2 Deepened anterior chamber on the day after Healon5™ injection. The bleb and 
anterior chamber are deepened and the intraocular pressure has decreased to 14 mmHg.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
384
Ozeki et alClinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Clinical Ophthalmology 2010:4
cases.6 Therefore, deepening the anterior chamber by an 
injection of Healon5TM in eyes similar to our case is also 
helpful for protecting corneal endothelial cell, and is an 
option to be considered.
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